Single-Cell Analysis of Crohn’s Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF TherapyJ.P. Martin, Ephraim Kenigsberg, Marla C. Dubinsky et al.|Cell|2019Cited by 902
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Ryan C. Ungaro et al.|Gastroenterology|2020Cited by 692
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2–related DiseaseMayte Suárez‐Fariñas, Saurabh Mehandru, Minami Tokuyama et al.|Gastroenterology|2020Cited by 131
Integrative Analysis of the Inflammatory Bowel Disease Serum Metabolome Improves Our Understanding of Genetic Etiology and Points to Novel Putative Therapeutic TargetsAntonio Di Narzo, Carmen Argmann, Sander M. Houten et al.|Gastroenterology|2021Cited by 87
Stopping 5-aminosalicylates in patients with ulcerative colitis starting biologic therapy does not increase the risk of adverse clinical outcomes: analysis of two nationwide population-based cohortsRyan C. Ungaro, Tine Jess|Gut|2018Cited by 65